Search - tctmd.com

Displaying 101 - 120 of 599

Sort: Relevancy | Date

Presentation TVT 2016

TAVR Valve Sizing and Positioning for Bicuspid Aortic Valve Disease: Is Undersized and Supraannular Best?

Presenter: Nicolo Piazza

June 16, 2016

Presentation TVT 2016

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Presenter: Hasan Jilaihawi

June 16, 2016

Presentation TVT 2016

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

Presenter: Jeffrey J. Popma

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

Presentation EuroPCR 2016

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Presenter: Patrick Serruys

May 20, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

Presentation EuroPCR 2016

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Presenter: Anna Franzone

May 19, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

News Conference News EuroPCR 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Industry News

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Industry News

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

May 16, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

Advertisement

TAVR Valve Sizing and Positioning for Bicuspid Aortic Valve Disease: Is Undersized and Supraannular Best?

A New CT-Based Diagnostic Schema for Classifying Bicuspid Aortic Valve Disease: Implications for TAVR Treatment

Epidemiology of Bicuspid Aortic Valve Disease in Younger Patients

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content